IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q1 2024 Holdings

Filed 2024-05-14 | 3 holdings | $135.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$77.5M2,346,93457.4%
Lyell Immunopharma IncCOM55083R104$45.0M20,162,33233.3%
Prime Medicine Inc(PRME)COM74168J101$12.5M1,792,2109.3%